Purple Biotech (PPBT) Short-term Investments (2016 - 2026)
Purple Biotech's Short-term Investments was $869,000 in Q2 2026, up 1.4% from $857,000 a year earlier and up 1.2% from the prior quarter.
Powered by 
Analysis
Purple Biotech (PPBT) Short-term Investments (2016 - 2026) Analysis & Trends
At the end of FY2025, Short-term Investments at Purple Biotech came in at $857,000, up 1.1% from FY2024.
- Short-term Investments shows a five-year compound annual growth rate of -55.0% (FY2020 to FY2025).
- In earlier years, Short-term Investments was $848,000 in FY2024 (-0.2%), $850,000 in FY2023 (-94.9%), $16.65 million in FY2022 (-54.1%) and $36.31 million in FY2021 (-22.0%).
- The Q2 2026 figure marks the highest quarterly Short-term Investments since Q4 2022.
- Compared with a year earlier, Short-term Investments has increased for five straight quarters, with growth averaging 0.9% over the last eight quarters.
- The best year-over-year quarter for Short-term Investments over five years was Q3 2025 (growth of 1.7%); the worst was Q3 2023 (a decline of 96.2%).
- Per Business Quant data, PPBT's Short-term Investments in the three quarters before Q2 2026 was $859,000 (Q1 2026), $857,000 (Q4 2025) and $862,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,172.05 Bn | 1,140.63 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 636.25 Bn | 554.77 Bn | 17.26 Bn |
| 3 | AbbVie | 503.38 Bn | 476.49 Bn | 12.70 Bn |
| 4 | Merck | 377.92 Bn | 332.30 Bn | 12.21 Bn |
| 5 | Novartis Ag | 304.19 Bn | 268.18 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.24 Bn | 240.93 Bn | 12.86 Bn |
| 7 | Amgen | 242.06 Bn | 197.46 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 193.78 Bn | 167.97 Bn | 6.22 Bn |
| 9 | Pfizer | 172.54 Bn | 119.18 Bn | 10.94 Bn |
| 10 | Purple Biotech | 535,259.51 | -32.02 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 869,000.00 |
| Mar 31, 2026 | 859,000.00 |
| Dec 31, 2025 | 857,000.00 |
| Sep 30, 2025 | 862,000.00 |
| Jun 30, 2025 | 857,000.00 |
| Mar 31, 2025 | 846,000.00 |
| Dec 31, 2024 | 848,000.00 |
| Sep 30, 2024 | 848,000.00 |
| Jun 30, 2024 | 845,000.00 |
| Mar 31, 2024 | 848,000.00 |
| Dec 31, 2023 | 850,000.00 |
| Sep 30, 2023 | 842,000.00 |
| Jun 30, 2023 | 846,000.00 |
| Mar 31, 2023 | 849,000.00 |
| Dec 31, 2022 | 16.65 Mn |
| Sep 30, 2022 | 22.01 Mn |
| Jun 30, 2022 | 22.01 Mn |
| Mar 31, 2022 | 16.01 Mn |
| Dec 31, 2021 | 36.31 Mn |
| Sep 30, 2021 | 36.45 Mn |
API Access
Purple Biotech Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=PPBT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "PPBT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=PPBT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();